Allogene Therapeutics, Inc. ( NASDAQ: ALLO) Citi's SMID Call Series 2025 October 2, 2025 1:00 PM EDT ...
Lennox is set for growth as R410a headwinds ease, with strong execution, margin expansion, and attractive valuation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback